Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$296.47
+2.1%
$293.30
$253.30
$339.17
$156.28B0.492.13 million shs2.17 million shs
Centene Corporation stock logo
CNC
Centene
$28.50
+5.8%
$37.47
$25.08
$80.59
$13.23B0.421.57 million shs19.60 million shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$304.02
+12.0%
$288.91
$234.60
$630.73
$245.88B0.4319.29 million shs67.93 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
+2.13%+2.86%-0.85%+8.83%-8.14%
Centene Corporation stock logo
CNC
Centene
+5.82%+11.42%-6.23%-53.87%-63.00%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
+11.86%+21.25%+4.05%+4.39%-47.53%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amgen Inc. stock logo
AMGN
Amgen
4.6642 of 5 stars
2.24.03.33.92.82.51.9
Centene Corporation stock logo
CNC
Centene
4.8876 of 5 stars
4.12.00.03.72.53.33.1
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4.967 of 5 stars
3.33.04.24.03.33.32.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amgen Inc. stock logo
AMGN
Amgen
2.33
Hold$303.762.46% Upside
Centene Corporation stock logo
CNC
Centene
2.12
Hold$42.2048.07% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.50
Moderate Buy$366.5220.56% Upside

Current Analyst Ratings Breakdown

Latest AMGN, CNC, and UNH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/6/2025
Amgen Inc. stock logo
AMGN
Amgen
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$305.00 ➝ $310.00
8/6/2025
Amgen Inc. stock logo
AMGN
Amgen
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$330.00 ➝ $333.00
8/6/2025
Amgen Inc. stock logo
AMGN
Amgen
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$326.00 ➝ $317.00
8/6/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$418.00 ➝ $310.00
8/4/2025
Centene Corporation stock logo
CNC
Centene
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$33.00 ➝ $28.00
8/4/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$306.00 ➝ $267.00
7/31/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/31/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Underperform$312.00 ➝ $198.00
7/30/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$355.00 ➝ $286.00
7/30/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$353.00 ➝ $317.00
7/30/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$400.00 ➝ $350.00
(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amgen Inc. stock logo
AMGN
Amgen
$34.92B4.57$31.01 per share9.56$13.80 per share21.48
Centene Corporation stock logo
CNC
Centene
$163.07B0.09$10.48 per share2.72$55.98 per share0.51
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$400.28B0.69$36.28 per share8.38$110.93 per share2.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amgen Inc. stock logo
AMGN
Amgen
$4.09B$12.2324.2413.862.5018.96%174.71%13.12%10/29/2025 (Estimated)
Centene Corporation stock logo
CNC
Centene
$3.31B$4.047.053.871.101.15%9.57%3.10%10/24/2025 (Estimated)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$14.41B$23.0813.179.151.755.04%23.32%7.66%10/21/2025 (Estimated)

Latest AMGN, CNC, and UNH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Amgen Inc. stock logo
AMGN
Amgen
$5.28$6.02+$0.74$2.65$8.86 billion$9.18 billion
7/29/2025Q2 2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$4.45$4.08-$0.37$3.74$111.75 billion$111.62 billion
7/25/2025Q2 2025
Centene Corporation stock logo
CNC
Centene
$0.23-$0.16-$0.39-$0.51$44.71 billion$48.74 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amgen Inc. stock logo
AMGN
Amgen
$9.523.21%N/A77.84%14 Years
Centene Corporation stock logo
CNC
Centene
N/AN/AN/AN/AN/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$8.842.91%N/A38.30%15 Years

Latest AMGN, CNC, and UNH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/13/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$2.213.38%9/15/20259/15/20259/23/2025
8/1/2025
Amgen Inc. stock logo
AMGN
Amgen
quarterly$2.383.21%8/22/20258/22/20259/12/2025
6/5/2025
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$2.213%6/16/20256/16/20256/24/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amgen Inc. stock logo
AMGN
Amgen
7.24
1.31
0.98
Centene Corporation stock logo
CNC
Centene
0.64
1.10
1.10
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.73
0.85
0.85

Institutional Ownership

CompanyInstitutional Ownership
Amgen Inc. stock logo
AMGN
Amgen
76.50%
Centene Corporation stock logo
CNC
Centene
93.63%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
87.86%

Insider Ownership

CompanyInsider Ownership
Amgen Inc. stock logo
AMGN
Amgen
0.76%
Centene Corporation stock logo
CNC
Centene
0.36%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amgen Inc. stock logo
AMGN
Amgen
28,000538.36 million534.27 millionOptionable
Centene Corporation stock logo
CNC
Centene
60,500491.13 million489.37 millionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
400,000905.67 million903.14 millionOptionable

Recent News About These Companies

Traders Buy High Volume of UnitedHealth Group Call Options (NYSE:UNH)
Zacks Research Brokers Reduce Earnings Estimates for UNH
Final Trade: UNH, VB, QQQ, LYFT
Stocks Log Second Weekly Win Despite Mixed Close
Dividend Stocks To Watch Now - August 14th
Financial markets news icon
How major US stock indexes fared Friday, 8/15/2025
...

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amgen stock logo

Amgen NASDAQ:AMGN

$296.47 +6.18 (+2.13%)
Closing price 08/15/2025 04:00 PM Eastern
Extended Trading
$296.32 -0.15 (-0.05%)
As of 08/15/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Centene stock logo

Centene NYSE:CNC

$28.50 +1.57 (+5.83%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$28.60 +0.09 (+0.33%)
As of 08/15/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.

UnitedHealth Group stock logo

UnitedHealth Group NYSE:UNH

$304.02 +32.53 (+11.98%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$305.20 +1.18 (+0.39%)
As of 08/15/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.